Regulation of matrix metalloproteinase-9 gene expression in MPP⁺- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells

Neuroscience

• Neuroblastoma 100%
• MMP9 100%
• MPP+ 100%
• Promoter Region 36%
• Neurotoxin 27%
• Parkinson's Disease 18%
• Reactive Oxygen Species 18%
• Dopaminergic 18%
• P38 Mitogen-Activated Protein Kinases 18%
• Neuronal Cell Death 9%
• Acetylcysteine 9%
• Cell Line 9%
• LY294002 9%
• Phosphoinositide 3-Kinase 9%
• Matrix Metalloproteinase 9%
• Free Radical 9%
• Cell Death 9%
• Phosphoinositide 3-Kinase Inhibitor 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Neuroblastoma 100%
• Gelatinase B 100%
• Neurotoxin 27%
• Reactive Oxygen Metabolite 18%
• Dopamine Receptor Stimulating Agent 18%
• Parkinson's Disease 18%
• Phosphatidylinositol 3 Kinase 9%
• Phosphatidylinositol 3 Kinase Inhibitor 9%
• 2 Morpholino 8 Phenylchromone 9%
• SB 203580 9%
• Matrix Metalloproteinase 9%
• N-Acetylcysteine 9%